The DOI matches its Crossref record; 260 of the 260 references it cites were found in a registry or an index.
NF-κB activation as a pathological mechanism of septic shock and inflammation
Abstract
The pathophysiology of sepsis and septic shock involves complex cytokine and inflammatory mediator networks. NF-κB activation is a central event leading to the activation of these networks. The role of NF-κB in septic pathophysiology and the signal transduction pathways leading to NF-κB activation during sepsis have been an area of intensive investigation. NF-κB is activated by a variety of pathogens known to cause septic shock syndrome. NF-κB activity is markedly increased in every organ studied, both in animal models of septic shock and in human subjects with sepsis. Greater levels of NF-κB activity are associated with a higher rate of mortality and worse clinical outcome. NF-κB mediates the transcription of exceptional large number of genes, the products of which are known to play important roles in septic pathophysiology. Mice deficient in those NF-κB-dependent genes are resistant to the development of septic shock and to septic lethality. More importantly, blockade of NF-κB pathway corrects septic abnormalities. Inhibition of NF-κB activation restores systemic hypotension, ameliorates septic myocardial dysfunction and vascular derangement, inhibits multiple proinflammatory gene expression, diminishes intravascular coagulation, reduces tissue neutrophil influx, and prevents microvascular endothelial leakage. Inhibition of NF-κB activation prevents multiple organ injury and improves survival in rodent models of septic shock. Thus NF-κB activation plays a central role in the pathophysiology of septic shock.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–260 of 260
Molecular Mechanisms for Lipopolysaccharide-induced Biphasic Activation of Nuclear Factor-κB (NF-κB)
Han, S.-J., Ko, H., Choi, J., Seo, K. H., Lee, H.-S., Choi, E.-K., Choi, I., Lee, H.-K., & Im, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202524200 · Cited by 74
Gene transfer of truncated IκBα prevents tubulointerstitial injury
Takase, O., Hirahashi, J., Takayanagi, A., Chikaraishi, A., Marumo, T., Ozawa, Y., Hayashi, M., Shimizu, N., & Saruta, T. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00781.x · Cited by 74
PKCζ participates in activation of inflammatory response induced by enteropathogenic E. coli
Savkovic, S. D., Koutsouris, A., & Hecht, G. A. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00444.2002 · Cited by 73
Transcriptional Regulation of Type I Diabetes by NF-κB
Lamhamedi-Cherradi, S.-E., Zheng, S. J., Hilliard, B. A., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4886 · Cited by 73
Pyrrolidine dithiocarbamate protects mice from lethal shock induced by LPS or TNF-α
Lauzurica, P., Martı́nez-Martı́nez, S., Marazuela, M., Arco, P. G., Martínez‐A, C., Sánchez‐Madrid, F., & Redondo, J. M. (1999) · European Journal of Immunology · Cited by 71
RIP Links TLR4 to Akt and Is Essential for Cell Survival in Response to LPS Stimulation
Vivarelli, M., McDonald, D. R., Miller, M. L., Cusson, N., Kelliher, M. A., & Geha, R. S. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040446 · Cited by 70
Laderach, D. J., Compagno, D., Danos, O., Vainchenker, W., & Galy, A. H. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1750 · Cited by 69
Interactions between CBP, NF-κB, and CREB in the lungs after hemorrhage and endotoxemia
Shenkar, R., Yum, H.-K., Arcaroli, J. J., Kupfner, J., & Abraham, E. H. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.2.l418 · Cited by 69
Nuclear factor κB is activated in small intestinal mucosa of celiac patients
Maiuri, M. C., Stefano, D. D., Mele, G., Fecarotta, S., Greco, L., Troncone, R., & Carnuccio, R. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0440-0 · Cited by 65
Peptide-directed Suppression of a Pro-inflammatory Cytokine Response
Liu, X. Y., Robinson, D., Veach, R. A., Liu, D., Timmons, S., Collins, R. D., & Hawiger, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000083200 · Cited by 64
Collin, M., Rossi, A., Cuzzocrea, S., Patel, N. S. A., Paola, R. D., Hadley, J., Collino, M., Sautebin, L., & Thiemermann, C. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0604338 · Cited by 63
Tussey, L., Nair, U. S., Bachinsky, M., Edwards, B. H., Bakari, J., Grimm, K. M., Joyce, J. G., Vessey, R., Steigbigel, R. T., Robertson, M. N., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/367707 · Cited by 62
Espinosa, L., Santos, S., Inglés‐Esteve, J., Muñoz‐Cánoves, P., & Bigas, A. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.6.1295 · Cited by 62
Frost, R. A., Nystrom, G. J., & Lang, C. H. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00010.2004 · Cited by 61
Eto, A., Muta, T., Yamazaki, S., & Takeshige, K. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)03082-6 · Cited by 61
Effects of NF-κB inhibition on mesenteric ischemia-reperfusion injury
Zou, L., Attuwaybi, B. O., & Kone, B. C. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00431.2002 · Cited by 61
Woods, M., Wood, E. G., Bardswell, S. C., Bishop‐Bailey, D., Barker, S., Wort, S. J., Mitchell, J. A., & Warner, T. D. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.4.923 · Cited by 60
Nuclear factor-kappa B plays a central role in tumour necrosis factor-mediated liver disease
Heyninck, K., Wullaert, A., & Beyaert, R. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00491-x · Cited by 59
Hall, A. J., Vos, H. L., & Bertina, R. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.376 · Cited by 59
Funakoshi‐Tago, M., Sonoda, Y., Tanaka, S., Hashimoto, K., Tago, K., Tominaga, S., & Kasahara, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213115200 · Cited by 59
Serio, K. J., Reddy, K. V., & Bigby, T. D. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00296.2004 · Cited by 58
Focus on oxidative stress in the cardiovascular and renal systems
Wilcox, C. S., & Gutterman, D. D. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00854.2004 · Cited by 57
Is Nuclear Factor κB an Attractive Therapeutic Target for Treating Cardiac Hypertrophy?
Purcell, N. H., & Molkentin, J. D. (2003) · Circulation · doi:10.1161/01.cir.0000085362.40608.dd · Cited by 57
Inhibition of nuclear factor- B activation by IRFI 042, protects against endotoxin-induced shock
Altavilla, D., Squadrito, G., Minutoli, L., Deodato, B., Bova, A., Sardella, A., Seminara, P., Passaniti, M., Urna, G., Venuti, S., et al. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00276-6 · Cited by 57
NF‐κB synergizes with NF‐AT and NF‐IL6 in activation of the IL‐4 gene in T cells
Li‐Weber, M., Giaisi, M., Baumann, S., Pálfi, K., & Krammer, P. H. (2004) · European Journal of Immunology · doi:10.1002/eji.200324687 · Cited by 56
小串, 伊., Iimuro, Y., Seki, E., Son, G., Hirano, T., Hada, T., Tsutsui, H., Nakanishi, K., Morishita, R., Kaneda, Y., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50298 · Cited by 56
Papin, S., Cazeneuve, C., Duquesnoy, P., Jéru, I., Sahali, D., & Amselem, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305166200 · Cited by 55
Ye, X., & Liu, S. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205544200 · Cited by 54
Self-citationMahabeleshwar, G. H., & Kundu, G. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308941200 · Cited by 53
Chantôme, A., Pance, A., Gauthier, N., Vandroux, D., Chenu, J., Solary, É., Jeannin, J., & Reveneau, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313731200 · Cited by 52
Regulation of NF-κB2 p100 Processing by Its cis-Acting Domain
Qing, G., Qu, Z., & Xiao, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406619200 · Cited by 52
Tamada, S., Nakatani, T., Asai, T., Tashiro, K., Komiya, T., Sumi, T., Okamura, M., Kim, S., Iwao, H., Kishimoto, T., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00714.x · Cited by 51
Recent advances in biological therapy for inflammatory bowel disease.
Kurtovic, J., & Segal, I. (2004) · PubMed · Cited by 50
Inhibition of NF-κB Activity by IκBβ in Association with κB-Ras
Chen, Y., Vallée, S., Wu, J., Vu, D., Sondek, J., & Ghosh, G. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.3048-3056.2004 · Cited by 49
NF-κB Promotes Survival during Mitotic Cell Cycle Arrest
Mistry, P., Deacon, K., Mistry, S. C., Blank, J. L., & Patel, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310413200 · Cited by 48
Acton, R. D., Dahlberg, P. S., Uknis, M. E., Klaerner, H. G., Fink, G. W., Norman, J. C., & Dunn, D. L. (1996) · Archives of Surgery · doi:10.1001/archsurg.1996.01430230098017 · Cited by 48
Fletcher, J. R. (1993) · Archives of Surgery · doi:10.1001/archsurg.1993.01420230020003 · Cited by 48
E2F-1 Regulates Nuclear Factor-κB Activity and Cell Adhesion
Chen, M., Capps, C., Willerson, J. T., & Zoldhelyi, P. (2002) · Circulation · doi:10.1161/01.cir.0000038706.30661.86 · Cited by 47
Ma, X., Wang, H., Ding, B., Zhong, H., Ghosh, S., & Lengyel, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302105200 · Cited by 45
Nitric oxide. A key mediator in sepsis and endotoxaemia?
Parratt, J. R. (1997) · PubMed · Cited by 44
Roles of Tumor Necrosis Factor Receptor Signaling during Murine Escherichia coli Pneumonia
Mizgerd, J. P., Peschon, J. J., & Doerschuk, C. M. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.1.3733 · Cited by 44
Imose, M., Nagaki, M., Kimura, K., Takai, S., Imao, M., Naiki, T., Osawa, Y., Asano, T., Hayashi, H., & Moriwaki, H. (2004) · Hepatology · doi:10.1002/hep.20438 · Cited by 43
Pocock, J., Gómez‐Guerrero, C., Harendza, S., Ayoub, M., Hernández-Vargas, P., Zahner, G., Stahl, R. A. K., & Thaiss, F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6280 · Cited by 40
Sheehan, M., Wong, H. R., Hake, P. W., & Zingarelli, B. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000085186.14867.f7 · Cited by 40
Coagulation in sepsis: all bugs bite equally.
Levi, M. M., & van der Poll, T. (2004) · Critical Care · doi:10.1186/cc2816 · Cited by 39
RelA Control of IκBα Phosphorylation
Yang, L., Ross, K., & Qwarnström, E. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212216200 · Cited by 39
Inhibition of NF-κB by ZAS3, a zinc-finger protein that also binds to the κB motif
Hong, J., Allen, C. E., & Wu, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2133048100 · Cited by 38
Snyder, J. G., Prewitt, R. L., Campsen, J., & Britt, L. D. (2002) · Shock · doi:10.1097/00024382-200204000-00011 · Cited by 38
Transcription Factor NFκB Expression and Postsurgical Organ Dysfunction
Foulds, S., Galustian, C., Mansfield, A. O., & Schächter, M. (2001) · Annals of Surgery · doi:10.1097/00000658-200101000-00012 · Cited by 35
Antisense Oligonucleotides to NF- κ B Improve Survival in Bleomycin-induced Pneumopathy of the Mouse
Zhang, X. Y., Shimura, S., MASUDA, T., Saitoh, H., & Shirato, K. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.4.9908093 · Cited by 35
Ikezoe, T., Yang, Y., Heber, D., Taguchi, H., & Koeffler, H. P. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.6.1521 · Cited by 34
Xu, M. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i16.2361 · Cited by 30
Nys, M., Deby-Dupont, G. P., Habraken, Y., Legrand-Poels, S., Kohnen, S. L., Ledoux, D., Canivet, J.-L., Damas, P., & Lamy, M. (2003) · Nitric Oxide · doi:10.1016/j.niox.2003.07.001 · Cited by 28
Cohen, S., Orian, A., & Ciechanover, A. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102448200 · Cited by 27
NF-??B ACTIVATION HAS TISSUE-SPECIFIC EFFECTS ON IMMUNE CELL APOPTOSIS DURING POLYMICROBIAL SEPSIS
Joshi, A. R. T., Chung, C., Song, G. Y., Lomas, J. L., Priester, R. A., & Ayala, A. (2002) · Shock · doi:10.1097/00024382-200210000-00015 · Cited by 27
Chapman, N., Webster, G., Gillespie, P. J., Wilson, B. J., Crouch, D. H., & Perkins, N. D. (2002) · Biochemical Journal · doi:10.1042/bj20020444 · Cited by 24
Impact of transcription factors AP-1 and NF-κB on the outcome of experimental arthritis and sepsis
Gjertsson, I., Hultgren, O., Collins, L. V., Pettersson, S., & Tarkowski, A. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01408-3 · Cited by 23
Transcriptional regulation of the MAIL gene in LPS-stimulated RAW264 mouse macrophages
Ito, T., Morimatsu, M., Oonuma, T., Shiina, T., Kitamura, H., & Syuto, B. (2004) · Gene · doi:10.1016/j.gene.2004.07.032 · Cited by 23
Kang, Y. J., Seo, S. J., Yun‐Choi, H. S., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.561 · Cited by 18
Xia, C., Watton, S. J., Nagl, S., Samuel, J., Lovegrove, J. U., Cheshire, J. K., & Woo, P. M. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00157-7 · Cited by 11
Research works printed but not linked: 20
- 10.1074/jbc.M211831200 · doi:10.1074/jbc.m211831200
- 10.1016/S0041-1345(01)02521-0 · doi:10.1016/s0041-1345(01)02521-0
- 10.1074/jbc.M201576200 · doi:10.1074/jbc.m201576200
- 10.1152/ajpheart.00394.2001 · DOI
- 10.1124/mol.64.6.1541 · doi:10.1124/mol.64.6.1541
- 10.1152/ajpheart.2001.280.4.H1464 · doi:10.1152/ajpheart.2001.280.4.h1464
- 10.1002/(SICI)1521-4141(199906)29:06<1890::AID-IMMU1890>3.0.CO;2-F · doi:10.1002/(sici)1521-4141(199906)29:06<1890::aid-immu1890>3.0.co;2-f
- 10.1002/(SICI)1097-4644(199701)64:1<27::AID-JCB5>3.0.CO;2-1 · doi:10.1002/(sici)1097-4644(199701)64:1<27::aid-jcb5>3.0.co;2-1
- 10.1074/jbc.M207515200 · doi:10.1074/jbc.m207515200
- 10.1016/j.ejcts.2004.09.016 · doi:10.1016/j.ejcts.2004.09.016
- 10.1016/S0076-6879(02)59191-6 · doi:10.1016/s0076-6879(02)59191-6
- 10.1097/00024382-200014020-00007 · doi:10.1097/00024382-200014020-00007
- 10.1152/ajpregu.00034.2002 · doi:10.1152/ajpregu.00034.2002
- 10.1172/JCI200319523 · DOI
- 10.1093/infdis/172.4.1001 · doi:10.1093/infdis/172.4.1001
- 10.4049/jimmunol.172.2.1054 · DOI
- 10.1152/ajpheart.1998.275.3.H1084 · DOI
- 10.1124/mol.61.5.953 · doi:10.1124/mol.61.5.953
- 10.1177/09680519020080020301 · doi:10.1177/09680519020080020301
- 10.1067/mtc.2001.115917 · doi:10.1067/mtc.2001.115917
Cited by
He, J., Zhang, P., Shen, L., Niu, L., Tan, Y., Chen, L., Zhao, Y., Bai, L., Hao, X., Li, X., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176356 · Cited by 1,064
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
Mechanisms and treatment of organ failure in sepsis
Lelubre, C., & Vincent, J.-L. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0005-7 · Cited by 852
Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells
Li, M., van Esch, B. C. A. M., Wagenaar, G. T. M., Garssen, J., Folkerts, G., & Henricks, P. A. J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.05.003 · Cited by 614
Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis
Mussbacher, M., Salzmann, M., Brostjan, C., Hoesel, B., Schoergenhofer, C., Datler, H., Hohensinner, P., Basílio, J., Petzelbauer, P., Assinger, A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00085 · Cited by 596
Metadata
- Authors
- Liu, S. F., & Malik, A. B.
- Venue
- American Journal of Physiology-Lung Cellular and Molecular Physiology
- Publisher
- American Physiological Society
- Published
- 2006-04
- Volume
- 290
- Issue
- 4
- Pages
- L622-L645
- ISSN
- 1040-0605 (ISSN-L)
- 1522-1504
- OpenAlex
- W1999325378
- Cited by
- 761
- References
- 260
- FWCI
- 29.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.